The BLOC1S1 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of HT29 cells featuring targeted disruption of the BLOC1S1 gene. This loss-of-function model is designed for studying BLOC1S1-dependent processes in lysosome-related organelle biogenesis and endosomal trafficking. As a heterogeneous knockout pool, the cells enable functional investigations without clonal selection artifacts. Researchers can employ this system to probe protein sorting and organelle maturation within an intestinal epithelial framework.
HT29, a human colorectal adenocarcinoma epithelial cell line, serves as a well-established model for colorectal cancer and intestinal biology. These cells retain characteristics of immature enterocytes and are capable of partial differentiation, providing a reproducible platform for examining trafficking, polarization, and secretion. The epithelial background of HT29 is particularly relevant for assessing membrane dynamics in tumor contexts.
BLOC1S1 is a subunit of the BLOC-1 complex, which coordinates cargo sorting from endosomes to melanosomes, lysosomes, and other LROs. BLOC1S1 forms complexes with BLOC1S2, BLOC1S3, pallidin, muted, cappuccino, and interacts with AP-3 and clathrin. This network directs trafficking of downstream targets such as tyrosinase and lysosomal enzymes. Knockout of BLOC1S1 disrupts BLOC-1 assembly, impairing routing of these proteins and leading to defective organelle biogenesis. The model thus aids in resolving how BLOC-1 interactions maintain endolysosomal homeostasis.
In HT29 cells, BLOC1S1 knockout impacts intracellular trafficking, offering a setting to study lysosomal enzyme sorting and degradation. Altered distribution of LAMP1 and endocytic cargo degradation can be assessed, revealing how loss of BLOC-1 function influences epithelial cancer cell biology. This model supports investigations into how colorectal tumor cells may exploit trafficking pathways, with implications for understanding lysosomal storage disorders and identifying novel therapeutic targets.
Applications include immunofluorescence microscopy for organelle markers, western blotting for lysosomal proteins, and EGFR degradation assays to measure endocytic flux. The cells are suitable for high-content screening of trafficking modulators and functional genomics studies. When combined with melanocytic models, they enable comparative analyses of pigmentation pathways. For researchers studying Hermansky-Pudlak syndrome, this tool provides a human cell-based platform to probe BLOC-1 complex function. For further details, please contact Ascent Research.
